《大行報告》匯豐研究調整中資保險股目標價 偏好中國平安(02318.HK)
匯豐研究發表報告,估計中資保險股新業務價值進一步下降,盈利受到市場的不利因素,以及賬面價值和內涵價值增長有限影響,估計2022年上半年新業務價值按年下跌20%-44%,代理人數目由2020年底的約800萬下跌至約400萬。
匯豐研究調整中資保險股目標價,未有調整評級,當中偏好中國平安(02318.HK)。目標價和評級詳見另表。
中資保險股表現似乎是由消息而非基本面驅動,因為人壽市場面臨挑戰,房地產敞口風險似乎反映在股價中。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.